Avelumab (anti-PD-L1) in platinum-resistant/refractory ovarian cancer: JAVELIN Ovarian 200 Phase III study design

Eric Pujade-Lauraine, Keiichi Fujiwara, Samuel S Dychter, Geeta Devgan, Bradley J Monk
  • Future Oncology, March 2018, Future Medicine
  • DOI: 10.2217/fon-2018-0070
The author haven't yet claimed this publicationThe author haven't yet claimed this publication

In partnership with: